Last $58.26 USD
Change Today +0.26 / 0.45%
Volume 3.7M
TEVA On Other Exchanges
Symbol
Exchange
New York
OTC US
Mexico
Tel Aviv
Frankfurt
As of 4:15 PM 12/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert Koremans M.D.

Chief Executive Officer of Global Specialty Medicines Group and President of Global Specialty Medicines Group, Teva Pharmaceutical Industries Limited
AgeTotal Calculated CompensationThis person is connected to 5 board members in 1 different organizations across 3 different industries.

See Board Relationships
52--

Background*

Mr. Robert Koremans, also known as Rob, M.D. has been Chief Executive Officer and President of Global Specialty Medicines Group at Teva Pharmaceutical Industries Limited since April 24, 2013. Mr. Koremans served as the Chief Executive Officer and President of Teva Europe at Teva Pharmaceutical Industries Limited since March 2012. He served as the Chairman and the Chief Executive Officer of Zentiva N.V. from July 1, 2010 to 2011 and its President from September 01, 2009 ...

Read Full Background

Corporate Headquarters*

5 Basel Street
Petach Tikva, -- 49131

Israel

Phone: 972 3 926 7267
Fax: 972 3 923 4050

Board Members Memberships*

2007-2009
Former Chief Executive Officer, Managing Director and director
2010-Present
Chairman, Chief Executive Officer and President

Education*

MD 1988
Erasmus University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TEVA:US $58.26 USD +0.26

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.8M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TEVA PHARMACEUTICAL-SP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.